NASHVILLE, Tenn., Aug. 2, 2023 /PRNewswire/ — Cryoport, Inc. CYRX (“Cryoport” or the “Company”), a leading global provider of innovative products and services for the fast growing cell and gene therapy industry, reproductive medicine and animal health industries, today announced that the Company will report financial results for the second…Read More
Cryoport to Report Second Quarter 2023 Financial Results on August 9 2023 CryoPort NASDAQCYRX
